MESTRONI, LUISA
 Distribuzione geografica
Continente #
NA - Nord America 6.372
EU - Europa 4.057
AS - Asia 3.371
SA - Sud America 444
AF - Africa 105
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 4
Totale 14.358
Nazione #
US - Stati Uniti d'America 6.272
SG - Singapore 1.321
PL - Polonia 1.265
IT - Italia 908
CN - Cina 776
VN - Vietnam 364
BR - Brasile 343
SE - Svezia 341
HK - Hong Kong 331
DE - Germania 293
FR - Francia 215
NL - Olanda 175
KR - Corea 173
GB - Regno Unito 163
FI - Finlandia 152
RU - Federazione Russa 117
UA - Ucraina 100
IN - India 79
TR - Turchia 79
IE - Irlanda 72
BG - Bulgaria 70
CA - Canada 51
JP - Giappone 40
AR - Argentina 37
CH - Svizzera 33
MA - Marocco 32
BD - Bangladesh 31
MX - Messico 30
ES - Italia 27
BE - Belgio 25
ID - Indonesia 24
ZA - Sudafrica 24
AT - Austria 20
IQ - Iraq 19
SA - Arabia Saudita 18
PK - Pakistan 15
EC - Ecuador 14
IR - Iran 12
CL - Cile 11
RS - Serbia 11
AE - Emirati Arabi Uniti 10
CO - Colombia 10
VE - Venezuela 9
JO - Giordania 8
KG - Kirghizistan 8
PH - Filippine 8
RO - Romania 8
TN - Tunisia 8
GR - Grecia 7
KE - Kenya 7
NP - Nepal 7
DZ - Algeria 6
EG - Egitto 6
IL - Israele 6
LT - Lituania 6
PT - Portogallo 6
SN - Senegal 6
AZ - Azerbaigian 5
HU - Ungheria 5
LV - Lettonia 5
MY - Malesia 5
PE - Perù 5
PY - Paraguay 5
SI - Slovenia 5
TT - Trinidad e Tobago 5
UZ - Uzbekistan 5
AL - Albania 4
AO - Angola 4
AU - Australia 4
BO - Bolivia 4
CZ - Repubblica Ceca 4
EU - Europa 4
JM - Giamaica 4
LB - Libano 4
NO - Norvegia 4
UY - Uruguay 4
BA - Bosnia-Erzegovina 3
CR - Costa Rica 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
KW - Kuwait 3
NG - Nigeria 3
TH - Thailandia 3
TW - Taiwan 3
BH - Bahrain 2
EE - Estonia 2
GA - Gabon 2
GE - Georgia 2
KZ - Kazakistan 2
LK - Sri Lanka 2
MD - Moldavia 2
PA - Panama 2
SK - Slovacchia (Repubblica Slovacca) 2
BN - Brunei Darussalam 1
BY - Bielorussia 1
CG - Congo 1
CM - Camerun 1
ET - Etiopia 1
FK - Isole Falkland (Malvinas) 1
GH - Ghana 1
Totale 14.343
Città #
Warsaw 1.181
Singapore 832
Ashburn 762
Fairfield 498
Chandler 454
Woodbridge 346
Hong Kong 320
San Jose 305
Houston 277
Ann Arbor 268
Wilmington 227
Chicago 224
Trieste 213
Beijing 211
Seattle 200
Cambridge 185
Seoul 162
Los Angeles 147
Dallas 142
Hefei 125
Ho Chi Minh City 112
Jacksonville 111
Boardman 110
Princeton 106
Hanoi 81
Helsinki 79
Santa Clara 77
Lauterbourg 76
Council Bluffs 73
Sofia 69
Columbus 68
Dublin 67
Milan 64
Zgierz 64
Munich 63
Frankfurt am Main 58
London 58
New York 51
Salt Lake City 50
Izmir 49
Moscow 48
São Paulo 41
Amsterdam 40
Dearborn 40
Rome 40
Buffalo 39
The Dalles 37
Dong Ket 30
Tokyo 30
Redwood City 29
San Diego 29
Düsseldorf 28
Nuremberg 28
Elk Grove Village 27
Tampa 27
Guangzhou 25
Lappeenranta 25
Phoenix 25
Brussels 24
Redondo Beach 23
Turku 22
Bremen 21
Orem 21
Bern 20
Casablanca 20
Falls Church 20
Da Nang 18
Denver 18
Poplar 17
Redmond 17
Sterling 17
Toronto 17
Turin 17
Atlanta 16
Grafing 16
Lancaster 16
Washington 16
Shanghai 15
Chennai 14
Johannesburg 14
Nanjing 14
Venice 14
Vienna 14
Miami 13
Palermo 13
Stockholm 13
Bexley 11
Des Moines 11
San Francisco 11
Baghdad 10
Belgrade 10
Boydton 10
Haiphong 10
Madrid 10
Miano 10
Montreal 10
Portsmouth 10
Manchester 9
Naples 9
Norwalk 9
Totale 9.773
Nome #
Current understanding of the role of cytoskeletal cross-linkers in the onset and development of cardiomyopathies 516
A Review of the Giant Protein Titin in Clinical Molecular Diagnostics of Cardiomyopathies 497
Natural History of Dilated Cardiomyopathy in Children 429
Role of Titin Missense Variants in Dilated Cardiomyopathy 416
Inquadramento e gestione delle cardiomiopatie: il protocollo della Cardiologia di Trieste 402
Filamin C Truncation Mutations Are Associated With Arrhythmogenic Dilated Cardiomyopathy and Changes in the Cell–Cell Adhesion Structures 388
Improving cardiac myocytes performance by carbon nanotubes platforms 380
FLNC Gene Splice Mutations Cause Dilated Cardiomyopathy 377
Knock Down of Plakophillin 2 Dysregulates Adhesion Pathway through Upregulation of miR200b and Alters the Mechanical Properties in Cardiac Cells 310
Cellular biomechanics impairment in keratinocytes is associated with a C-terminal truncated desmoplakin: An atomic force microscopy investigation 284
Altered microtubule structure, hemichannel localization and beating activity in cardiomyocytes expressing pathologic nuclear lamin A/C 284
Biomechanical defects and rescue of cardiomyocytes expressing pathologic nuclear lamins 281
The giant protein Titin’s role in cardiomyopathy: genetic, transcriptional, and post translational modifications of TTN and their contribution to cardiac disease 262
Historical Terminology, Classifications, and Present Definition of DCM. 262
Carbon nanotube facilitation of myocardial ablation with radiofrequency energy 253
Chapter 5: Genetics of Dilated Cardiomyopathy: Current Knowledge and Future Perspectives 246
Genetics of Dilated Cardiomyopathy: Clinical Implications 244
Easy fabrication of aligned PLLA nanofibers-based 2D scaffolds suitable for cell contact guidance studies 243
Titin and desmosomal genes in the natural history of arrhythmogenic right ventricular cardiomyopathy 230
Arrhythmogenic right ventricular cardiomyopathy: Arrhythmogenic right ventricular cardiomyopathy: Clinical assessment and differential diagnosis 228
The role of clinical observation: Red flag 6-left ventricular non-compaction 227
Regional Variation in RBM20 Causes a Highly Penetrant Arrhythmogenic Cardiomyopathy 225
The role of clinical observation: Red flag 7-syndromic and multi-system cardiomyopathies 221
Genetic and Phenotypic Characterization of Nexilin (NEXN)-Related Cardiomyopathy: Results From a Multicentric Study 211
Prevalence and evolution of right ventricular dysfunction among different genetic backgrounds in dilated cardiomyopathy 205
Contemporary survival trends and aetiological characterization in non-ischaemic dilated cardiomyopathy 200
Association of Titin Variations with Late-Onset Dilated Cardiomyopathy 196
Early Arrhythmic Events in Idiopathic Dilated Cardiomyopathy 189
Trattamento dello scompenso cardiaco con terapia genica: i risultati inattesi del trial CUPID 2 176
Danon Disease-Associated LAMP-2 Deficiency Drives Metabolic Signature Indicative of Mitochondrial Aging and Fibrosis in Cardiac Tissue and hiPSC-Derived Cardiomyocytes 175
SCN5A Mutations Associate With Arrhythmic Dilated Cardiomyopathy and Commonly Localize to the Voltage-Sensing Mechanism. 172
Introduction 172
Viscoelastic behavior of cardiomyocytes carrying LMNA mutations 169
Antiarrhythmic therapy and risk of cumulative ventricular arrhythmias in arrhythmogenic right ventricle cardiomyopathy 169
Clinical Spectrum of PRKAG2 Syndrome 167
Clinical Risk Score to Predict Pathogenic Genotypes in Patients With Dilated Cardiomyopathy 165
Atomic Force Microscopy (AFM) applications in arrhythmo-genic cardiomyopathy 162
Clinical features and outcomes in carriers of pathogenic desmoplakin variants 158
Sex differences in natural history of cardiovascular magnetic resonance- and biopsy-proven lymphocytic myocarditis 158
Phenotypic Expression, Natural History and Risk Stratification of Cardiomyopathy Caused by Filamin C Truncating Variants 157
Prognostic role of exercise intensity in familial Filamin C truncating variants 153
Arrhythmic Risk Stratification of Carriers of Filamin C Truncating Variants 151
Cellular Biomechanic Impairment in Cardiomyocytes Carrying the Progeria Mutation: An Atomic Force Microscopy Investigation 151
AFM macro-probes to investigate whole 3D cardiac spheroids 151
Impact of DCM-Causing Genetic Background on Long-Term Response to Cardiac Resynchronization Therapy 147
Lamin A/C Cardiomyopathy: Implications for Treatment 146
A novel tool for arrhythmic risk stratification in desmoplakin gene variant carriers 144
Magnetic Resonance Imaging Characterization and Clinical Outcomes of Dilated and Arrhythmogenic Left Ventricular Cardiomyopathies 140
The electrocardiogram in the diagnosis and management of patients with dilated cardiomyopathy 138
Carbon Nanotubes for Cardiac Applications 138
The response to cardiac resynchronization therapy in LMNA cardiomyopathy 138
Microfabricated cantilevers for parallelized cell-cell adhesion measurements 133
Risk Stratification in Arrhythmic Right Ventricular Cardiomyopathy Without Implantable Cardioverter-Defibrillators 132
Ankyrin-B dysfunction predisposes to arrhythmogenic cardiomyopathy and is amenable to therapy 129
A Systematic Analysis of the Clinical Outcome Associated with Multiple Reclassified Desmosomal Gene Variants in Arrhythmogenic Right Ventricular Cardiomyopathy Patients 128
The Arrhythmic Phenotype in Cardiomyopathy 128
Molecular and Cellular Mechanisms in Heart Failure 127
Investigations of cardiac fibrosis rheology by in vitro cardiac tissue modeling with 3D cellular spheroids 126
null 121
Activation of PDGFRA signaling contributes to filamin C–related arrhythmogenic cardiomyopathy 121
The genetic architecture of Plakophilin 2 cardiomyopathy 116
null 112
CARBON NANOTUBE SCAFFOLDS FOR CARDIAC TISSUE ENGINEERING 111
Compromised Biomechanical Properties, Cell–Cell Adhesion and Nanotubes Communication in Cardiac Fibroblasts Carrying the Lamin A/C D192G Mutation 110
Neonatal rat ventricular myocytes interfacing conductive polymers and carbon nanotubes 108
Arrhythmogenic right ventricular cardiomyopathy: From genetics to diagnostic and therapeutic challenges 104
null 103
Gold Nanoparticle-Functionalized Reverse Thermal Gel for Tissue Engineering Applications 102
Multilevel analyses of SCN5A mutations in arrhythmogenic right ventricular dysplasia/cardiomyopathy suggest non-canonical mechanisms for disease pathogenesis 101
Valutazione dell’ereditarietà e analisi molecolare alla luce delle nuove linee guida europee sulla cardiomiopatia ipertrofica 101
The Sarcomeric Spring Protein Titin: Biophysical Properties, Molecular Mechanisms, and Genetic Mutations Associated with Heart Failure and Cardiomyopathy 93
Genetic causes of dilated cardiomyopathy 92
FLNC truncations cause arrhythmogenic right ventricular cardiomyopathy 92
Prediction and prognostic role of left ventricular systolic dysfunction in family screening for dilated cardiomyopathy and non-dilated left ventricular cardiomyopathy 87
Myocardial Recovery in Recent Onset Dilated Cardiomyopathy: Role of CDCP1 and Cardiac Fibrosis 80
Risks of Ventricular Arrhythmia and Heart Failure in Carriers of RBM20 Variants 64
Titin-related familial dilated cardiomyopathy: factors associated with disease onset 58
Integrated role of cardiac magnetic resonance and genetics in predicting left ventricular reverse remodelling in dilated and non-dilated cardiomyopathy 47
Prognostic Role of Myocarditis-Like Episodes and Their Treatment in Patients With Pathogenic Desmoplakin Variants 44
Sex Differences in Prognosis of Patients With Genetic Dilated Cardiomyopathy 43
Impact of genotype-phenotype associations on prognosis in dilated cardiomyopathy 38
Future development of arrhythmogenic risk scores in patients with heart failure and inherited dilated cardiomyopathy. A scientific statement of the Heart Failure Association of the ESC 26
Twenty-Five-Year Follow-Up of the MDDC1 Family: A LMNA Gene Variant Associated With Dilated Cardiomyopathy With Variable Skeletal Muscle Involvement 12
Totale 14.792
Categoria #
all - tutte 39.979
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.979


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021264 0 0 0 0 0 0 0 0 0 132 52 80
2021/2022941 68 79 64 47 52 82 47 27 103 91 56 225
2022/20231.250 105 172 136 198 112 197 17 112 124 18 40 19
2023/2024902 58 49 66 67 73 118 143 128 18 26 93 63
2024/20252.174 24 151 200 169 183 157 119 124 270 305 238 234
2025/20265.269 865 345 541 545 481 436 726 198 539 593 0 0
Totale 14.792